Completed PHASE3 INTERVENTIONAL 2-arm NCT00621907

Study : LEVOBUPIVACAINE Versus Placebo (LEVOBU)

Levobupivacïne Into Post-analgesia : Randomized Monocentric Study Against Placebo

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Conditions Pain

Interventions chirocaine (Levobupivacaine) sodium chloride

Updated 5 times since 2017 Last updated: Sep 15, 2010 Started: Mar 31, 2008 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Pain, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire de Saint Etienne and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Saint Etienne

Data source: Centre Hospitalier Universitaire de Saint Etienne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Etienne, France